2020
DOI: 10.1016/j.cmet.2020.10.010
|View full text |Cite
|
Sign up to set email alerts
|

TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
57
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(58 citation statements)
references
References 59 publications
0
57
0
1
Order By: Relevance
“…Intriguingly, ACSL1 localization at mitochondria appears to be regulated by TANK-Binding Kinase 1 in response to fasting. Relocalization of ACSL1 to mitochondria subsequently increases β-oxidation (Huh et al ., 2020). Similarly, the ER-LD tethering protein Snx14 interacts with ACSL4 (Datta et al ., 2020), an isoenzyme of which localizes to ER/LDs (Küch et al ., 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Intriguingly, ACSL1 localization at mitochondria appears to be regulated by TANK-Binding Kinase 1 in response to fasting. Relocalization of ACSL1 to mitochondria subsequently increases β-oxidation (Huh et al ., 2020). Similarly, the ER-LD tethering protein Snx14 interacts with ACSL4 (Datta et al ., 2020), an isoenzyme of which localizes to ER/LDs (Küch et al ., 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have clearly established the causality of TBK1 in the pathogenesis of NAFLD (Reilly et al, 2013;Cruz et al, 2018;Huh et al, 2020) although the regulation of its expression and/or activity is not completely understood. Here we provide evidence to show that BRG1 plays dual roles in the regulation of FIGURE 2 | BRG1 interacts with AP-1 to activate TBK1 transcription.…”
Section: Discussionmentioning
confidence: 99%
“…TBK1 is an atypical kinase whose activity is primarily regulated by autophosphorylation although upstream priming kinases for TBK1 have also been reported (Ma et al, 2012). Mounting evidence suggests that TBK1 is a regulator of NAFLD pathogenesis by programming the innate immune response and by altering hepatic metabolism (Reilly et al, 2013;Cruz et al, 2018;Huh et al, 2020). However, it is not clear (1) whether or not BRG1 may influence TBK1 expression/activity and (2) whether TBK1 may regulate ROS production in the context of NAFLD.…”
Section: Introductionmentioning
confidence: 99%
“…Beyond its well-known role in innate immunity, TBK1 has been implicated in oncogenesis and metabolic disorders linked to obesity such as type II diabetes, similar to mTOR and Akt (14)(15)(16)(17)28,(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54). In oncogenic KRas transformed cells, TBK1 promotes cell proliferation and survival and the growth of tumor explants in vivo, with either mTORC1 or Akt suggested as downstream mediators of TBK1 action (14)(15)(16)(17)(42)(43)(44)(45)(46).…”
Section: Introductionmentioning
confidence: 99%